SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-034079
Filing Date
2024-02-13
Accepted
2024-02-13 18:46:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d784098dsc13ga.htm SC 13G/A 47495
  Complete submission text file 0001193125-24-034079.txt   49168
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 24630859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON BOSTON MA 02116
Business Address 200 CLARENDON BOSTON MA 02116 6175162000
BCLS II Equity Opportunities, LP (Filed by) CIK: 0001814474 (see all company filings)

IRS No.: 850698036 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A